Valproate prescribing practices for women with intellectual disability across Europe.

Lance WatkinsMarkus ReuberBhathika PereraKen CourtenayRoger BanksEmma MurphyHeather Angus-Leppan Richard Laugharne

Published in: Acta neurologica Scandinavica (2020)

There is heterogeneity in the application of VPA regulations across Europe for women/girls with ID. In both the UK and Europe, the regulations lack suitable adjustments for specific ID-related factors.

Keyphrases

intellectual disability
primary care
autism spectrum disorder
healthcare
polycystic ovary syndrome
single cell
emergency department
cross sectional
skeletal muscle
insulin resistance
adverse drug
breast cancer risk